Astragaloside IV can reduce the expression of miR-192 and inhibit renal mesangial hyperproliferation and renal fibrosis via the TGF-β1/Smad/miR-192 signaling pathway [38]. The gene discussed is TGFB1; the disease is renal fibrosis.